Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1994;90:677-685

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X. M.
Right arrow Articles by Miller, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X. M.
Right arrow Articles by Miller, G. G.

Circulation, Vol 90, 677-685, Copyright © 1994 by American Heart Association


ARTICLES

Induction of acidic fibroblast growth factor and full-length platelet- derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry

XM Zhao, TK Yeoh, WH Frist, DL Porterfield and GG Miller
Vanderbilt Transplant Center, Nashville, Tenn.

BACKGROUND: Further understanding of cardiac allograft vasculopathy (CAV) is needed to improve long-term survival after cardiac transplantation. The diffuse hyperplasia of coronary intima characteristic of CAV suggests that growth factors may play a role in the development of CAV. Fibroblast growth factor (FGF) and platelet- derived growth factor (PDGF) are potent mitogens for smooth muscle cells (SMCs), and PDGF is an important cofactor in the pathogenesis of native coronary atherosclerosis. METHODS AND RESULTS: Reverse transcriptase/polymerase chain reaction (RT/PCR), in situ hybridization, and immunohistochemistry were used to determine whether transplantation results in increased cardiac expression of acidic (a) FGF, basic (b) FGF, and PDGF-A and -B chains. Sixty-eight myocardial biopsies from 36 heart transplant recipients and 7 normal hearts were analyzed by PCR. aFGF mRNA was present in 54 of 61 allograft biopsies and was not found in any normal heart. In situ hybridization and immunohistochemistry demonstrated diffuse, intense expression of a FGF mRNA and protein in allograft biopsies, predominantly in myocytes and vascular walls. Only scattered aFGF expression was observed in normal hearts. mRNA for the full-length isoform of PDGF-A chain was found in 43 of 61 allograft biopsies and was not detected in any normal heart. In situ hybridization and immunohistochemistry confirmed that full- length PDGF-A chain mRNA and PDGF protein were present in myocytes and vascular walls. CONCLUSIONS: Expression of aFGF and PDGF-A chain is significantly increased in cardiac allografts. Cardiac myocytes and vascular walls are the predominant sources of aFGF and PDGF. Diffuse expression of these growth factors in cardiac allografts may be important in the pathogenesis of CAV.


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Tuuminen, A. I. Nykanen, R. Krebs, J. Soronen, K. Pajusola, M. A.I. Keranen, P. K. Koskinen, K. Alitalo, and K. B. Lemstrom
PDGF-A, -C, and -D but not PDGF-B Increase TGF-{beta}1 and Chronic Rejection in Rat Cardiac Allografts
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Koch, E. Palchyk, N. Gassler, T. J. Dengler, A. Remppis, M. Pritsch, F.-U. Sack, S. Hagl, and P. A. Schnabel
Expression of Platelet-Derived Growth Factor and Fibroblast Growth Factor in Cryopreserved Endomyocardial Biopsies Early and Late After Heart Transplant
Ann. Thorac. Surg., April 1, 2006; 81(4): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. Luo, A. Liu, Y. Chen, H. M. Lim, J. Marshall-Neff, J. H. Black, W. Baldwin III, R. H. Hruban, S. C. Stevenson, P. Mouton, et al.
Inhibition of Accelerated Graft Arteriosclerosis by Gene Transfer of Soluble Fibroblast Growth Factor Receptor-1 in Rat Aortic Transplants
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. X.-M. Zhao, Y. Hu, G. G. Miller, A. D. Luster, R. N. Mitchell, and P. Libby
Differential Expression of the IFN-{gamma}-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell {alpha} Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection
J. Immunol., August 1, 2002; 169(3): 1556 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Okada, C. Y. Wang, D. W. Hwang, T. Sakaguchi, K. E. Olson, Y. Yoshikawa, K. Minamoto, S. P. Mazer, S.-F. Yan, and D. J. Pinsky
Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1)
Circ. Res., July 26, 2002; 91(2): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X.-M. Zhao, Y. Hu, G. G. Miller, R. N. Mitchell, and P. Libby
Association of Thrombospondin-1 and Cardiac Allograft Vasculopathy in Human Cardiac Allografts
Circulation, January 30, 2001; 103(4): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. A. KALLIO, P. K. KOSKINEN, E. AAVIK, E. BUCHDUNGER, and K. B. LEMSTRÖM
Role of Platelet-derived Growth Factor in Obliterative Bronchiolitis (Chronic Rejection) in the Rat
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1324 - 1332.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
H. Bian and E. F. Reed
Alloantibody-Mediated Class I Signal Transduction in Endothelial Cells and Smooth Muscle Cells: Enhancement by IFN-{gamma} and TNF-{alpha}
J. Immunol., July 15, 1999; 163(2): 1010 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Nath, H. Bian, E. F. Reed, and S. P. Chellappan
HLA Class I-Mediated Induction of Cell Proliferation Involves Cyclin E-Mediated Inactivation of Rb Function and Induction of E2F Activity
J. Immunol., May 1, 1999; 162(9): 5351 - 5358.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Lou, M. B. Martin, A. Stoica, P. W. Ramwell, and M. L. Foegh
Upregulation of Estrogen Receptor-{alpha} Expression in Rabbit Cardiac Allograft
Circ. Res., November 2, 1998; 83(9): 947 - 951.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Dikov, M. B. Reich, L. Dworkin, J. W. Thomas, and G. G. Miller
A Functional Fibroblast Growth Factor-1 Immunoglobulin Fusion Protein
J. Biol. Chem., June 19, 1998; 273(25): 15811 - 15817.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. B. Lemstrom and P. K. Koskinen
Expression and Localization of Platelet-Derived Growth Factor Ligand and Receptor Protein During Acute and Chronic Rejection of Rat Cardiac Allografts
Circulation, August 19, 1997; 96(4): 1240 - 1249.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Ravalli, M. Szabolcs, A. Albala, R. E. Michler, and P. J. Cannon
Increased Immunoreactive Endothelin-1 in Human Transplant Coronary Artery Disease
Circulation, November 1, 1996; 94(9): 2096 - 2102.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. S. F. Clarke, R. W. Caldwell, H. Chiao, K. Miyake, and P. L. McNeil
Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in Heart
Circ. Res., June 1, 1995; 76(6): 927 - 934.
[Abstract] [Full Text]